Dr. Michael Cochran, PhDDirector of Chemistry at Avidity BiosciencesSpeaker
Profile
Scientist with over ten years of experience in industry developing antibody-oligonucleotide conjugates, nanoparticles, and antigen-adjuvant conjugates to improve treatments for rare muscular diseases, oncology, and vaccines. At Avidity, Michael has worked on the chemistry of antibody-siRNA and PMO conjugates from preclinical discovery through GMP manufacturing.
Agenda Sessions
Recent Progress with Antibody PMO Conjugates
, 10:45amView Session